CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,265,000 | +182.0% | 313,167 | +6.2% | 0.00% | – |
| Q3 2019 | $1,158,000 | -83.3% | 294,843 | -36.6% | 0.00% | -100.0% |
| Q2 2019 | $6,915,000 | -40.1% | 464,975 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $11,540,000 | +38.2% | 464,975 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $8,351,000 | -38.9% | 464,975 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $13,657,000 | -35.4% | 464,975 | 0.0% | 0.00% | -42.9% |
| Q2 2018 | $21,143,000 | -13.9% | 464,975 | 0.0% | 0.01% | -22.2% |
| Q1 2018 | $24,551,000 | -27.2% | 464,975 | -6.2% | 0.01% | -25.0% |
| Q4 2017 | $33,705,000 | -12.6% | 495,656 | +5.9% | 0.01% | -20.0% |
| Q3 2017 | $38,562,000 | -18.5% | 467,979 | -7.4% | 0.02% | -21.1% |
| Q2 2017 | $47,328,000 | +68.2% | 505,482 | +14.4% | 0.02% | +58.3% |
| Q1 2017 | $28,132,000 | +113.9% | 441,854 | +49.2% | 0.01% | +100.0% |
| Q4 2016 | $13,155,000 | +40.7% | 296,145 | +9.1% | 0.01% | +50.0% |
| Q3 2016 | $9,350,000 | +206.2% | 271,545 | +22.0% | 0.00% | +300.0% |
| Q2 2016 | $3,054,000 | -28.5% | 222,573 | 0.0% | 0.00% | -50.0% |
| Q1 2016 | $4,273,000 | -45.1% | 222,573 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $7,790,000 | -61.9% | 222,573 | 0.0% | 0.00% | -63.6% |
| Q3 2015 | $20,468,000 | +35.7% | 222,573 | +29.7% | 0.01% | +37.5% |
| Q2 2015 | $15,086,000 | +18.4% | 171,663 | 0.0% | 0.01% | +33.3% |
| Q1 2015 | $12,743,000 | +45.1% | 171,663 | +9.4% | 0.01% | +50.0% |
| Q4 2014 | $8,784,000 | +79.7% | 156,861 | +45.6% | 0.00% | +33.3% |
| Q3 2014 | $4,888,000 | -66.7% | 107,751 | -69.6% | 0.00% | -25.0% |
| Q2 2014 | $14,658,000 | – | 353,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |